PJP · Invesco Pharmaceuticals ETF ETF
Invesco Exchange-Traded Fund Trust
$129.15
-0.34%
At close · Sep 4
Net assets $333,093,288
Holdings29
1 month
+3.44%
Year to date
+24.23%
52-week range
$90.01–$131.68
30-session avg volume
36,144
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000003031
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Pfizer Inc. | PFE | $17,365,520 | 5.21% |
| Johnson & Johnson | JNJ | $16,479,555 | 4.95% |
| AbbVie Inc. | ABBV | $16,328,062 | 4.90% |
| Amgen Inc. | AMGN | $15,962,471 | 4.79% |
| Eli Lilly and Co. | LLY | $15,845,208 | 4.76% |
| Gilead Sciences, Inc. | GILD | $15,642,315 | 4.70% |
| Merck & Co., Inc. | MRK | $15,549,634 | 4.67% |
| Abbott Laboratories | ABT | $13,988,197 | 4.20% |
| Travere Therapeutics, Inc. | TVTX | $13,333,844 | 4.00% |
| Corcept Therapeutics Inc. | CORT | $12,465,778 | 3.74% |
| Ligand Pharmaceuticals Inc. | LGND | $11,863,024 | 3.56% |
| United Therapeutics Corp. | UTHR | $11,795,521 | 3.54% |
| Liquidia Corp. | LQDA | $11,417,952 | 3.43% |
| Jazz Pharmaceuticals PLC | JAZZ | $11,415,612 | 3.43% |
| Harmony Biosciences Holdings, Inc. | HRMY | $10,840,280 | 3.25% |
| Ocular Therapeutix, Inc. | OCUL | $10,229,145 | 3.07% |
| ANI Pharmaceuticals, Inc. | ANIP | $10,125,585 | 3.04% |
| Bristol-Myers Squibb Co. | BMY | $9,616,057 | 2.89% |
| Innoviva, Inc. | INVA | $9,596,072 | 2.88% |
| Biogen Inc. | BIIB | $9,479,900 | 2.85% |
| Viatris Inc. | VTRS | $9,091,124 | 2.73% |
| Regeneron Pharmaceuticals, Inc. | REGN | $8,942,188 | 2.68% |
| Supernus Pharmaceuticals, Inc. | SUPN | $8,803,248 | 2.64% |
| Amneal Pharmaceuticals, Inc. | AMRX | $8,582,450 | 2.58% |
| Tarsus Pharmaceuticals, Inc. | TARS | $8,289,655 | 2.49% |
| Prestige Consumer Healthcare Inc. | PBH | $8,003,523 | 2.40% |
| Perrigo Co. PLC | PRGO | $7,922,748 | 2.38% |
| Amphastar Pharmaceuticals, Inc. | AMPH | $7,758,753 | 2.33% |
| Collegium Pharmaceutical, Inc. | COLL | $7,299,206 | 2.19% |